WO2009093258A3 - A new and improved process for the preparation of ibandronate sodium monohydrate - Google Patents

A new and improved process for the preparation of ibandronate sodium monohydrate Download PDF

Info

Publication number
WO2009093258A3
WO2009093258A3 PCT/IN2008/000454 IN2008000454W WO2009093258A3 WO 2009093258 A3 WO2009093258 A3 WO 2009093258A3 IN 2008000454 W IN2008000454 W IN 2008000454W WO 2009093258 A3 WO2009093258 A3 WO 2009093258A3
Authority
WO
WIPO (PCT)
Prior art keywords
formula
methyl
preparation
new
improved process
Prior art date
Application number
PCT/IN2008/000454
Other languages
French (fr)
Other versions
WO2009093258A2 (en
Inventor
Ravishankar Balasubramaniam
Pulla Rao Polsani
Gowri Naidu Tammireddy
Original Assignee
Fleming Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fleming Laboratories Limited filed Critical Fleming Laboratories Limited
Publication of WO2009093258A2 publication Critical patent/WO2009093258A2/en
Publication of WO2009093258A3 publication Critical patent/WO2009093258A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/386Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention discloses a new and an improved process for preparation of Ibandronate sodium monohydrate. According to the process pentylamine is reacted with ethylacrylate to give N-pentyl-β-alanine ethyl ester (XXIV), which on methylation provided N-methyl-N-pentyl-β-alanine ethylester formula (XXV). The reresulting ester on hydrolysis and subsequent treatment with hydrochloric acid furnished 3-(N-methyl-N-pentylamino)propionic acid hydrochloride formula (II). Bisphosphorylation of 3-(N-methyl-N-pentylamino)propionic acid hydrochloride formula (II) with phosphorous acid and phosphorous trichloride followed by hydrolysis and subsequent treatment with a base provided Ibandronate monosodium monohydrate of formula (I).
PCT/IN2008/000454 2008-01-24 2008-07-16 A new and improved process for the preparation of ibandronate sodium monohydrate WO2009093258A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN189CH2008 2008-01-24
IN189/CHE/2008 2008-01-24
IN679CH2008 2008-03-19
IN679/CHE/2008 2008-03-19

Publications (2)

Publication Number Publication Date
WO2009093258A2 WO2009093258A2 (en) 2009-07-30
WO2009093258A3 true WO2009093258A3 (en) 2011-01-20

Family

ID=40901513

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000454 WO2009093258A2 (en) 2008-01-24 2008-07-16 A new and improved process for the preparation of ibandronate sodium monohydrate

Country Status (1)

Country Link
WO (1) WO2009093258A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011016738A1 (en) * 2009-08-05 2011-02-10 Zaklady Farmaceutyczne Polpharma Sa A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate
EP2609101B1 (en) 2010-07-14 2015-01-28 Pharmathen S.A. Process for the preparation of 3-(n-methyl-n-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid salt or derivatives thereof
CN103450064A (en) * 2013-07-30 2013-12-18 中国科学院上海微系统与信息技术研究所 Preparation method for aryl vinyl propylene imide and detection method for primary amine
CN103396332A (en) * 2013-08-19 2013-11-20 四川协力制药有限公司 3-[(N-methyl-N-pentyl)amino]propionic acid hydrochloride preparation method
CN109608492B (en) * 2018-12-19 2021-02-09 深圳市第二人民医院 Diphosphonic acid compound for osteoporosis and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252504A1 (en) * 1986-07-11 1988-01-13 Roche Diagnostics GmbH Diphosphonic-acid derivatives, process for their preparation and medicines containing these compounds
WO2006045578A2 (en) * 2004-10-29 2006-05-04 F. Hoffmann-La Roche Ag Process for the preparation of ibandronate
WO2007013097A1 (en) * 2005-07-25 2007-02-01 Natco Pharma Limited Improved process for the preparation of ibandronate sodium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252504A1 (en) * 1986-07-11 1988-01-13 Roche Diagnostics GmbH Diphosphonic-acid derivatives, process for their preparation and medicines containing these compounds
WO2006045578A2 (en) * 2004-10-29 2006-05-04 F. Hoffmann-La Roche Ag Process for the preparation of ibandronate
WO2007013097A1 (en) * 2005-07-25 2007-02-01 Natco Pharma Limited Improved process for the preparation of ibandronate sodium

Also Published As

Publication number Publication date
WO2009093258A2 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
CY1121703T1 (en) MEDICAL USE OF POLYMORPH A OF IBANDRONIC
WO2008022777A8 (en) Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
TW200640940A (en) Ibandronate polymorph B
WO2009093258A3 (en) A new and improved process for the preparation of ibandronate sodium monohydrate
IL182690A0 (en) Process for the preparation of ibandronate
NZ598012A (en) Processes for the preparation of 1,2,4-oxadiazole benzoic acids
WO2008007392A3 (en) Process for the preparation of tenofovir
HK1160836A1 (en) Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl 4-- hc1
UA103997C2 (en) Method for stereoselective enzymatic hydrolysis of 5-melhyl-3-nitromethyl-hexanoic acid ester
HK1139385A1 (en) A process for preparing r-beta-amino phenylbutyric acid derivatives r--
WO2011015287A3 (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
NZ593102A (en) Dihydroetorphines and their preparation
BRPI0821752A8 (en) PROCESS FOR PREPARING 22-FLUORACYL-3-AMINO-ACRYLIC ACID DERIVATIVES
WO2010089267A3 (en) Method for producing 2-halogenomethylphenyl acetic acid derivatives
IL198965A0 (en) Process for preparation of abacavir
AU2007270897A8 (en) Novel process for the preparation of bisphosphonic acids
WO2008014510A3 (en) Crystalline form a of ibandronic acid and process for the preparation
WO2008125483A3 (en) Multi step synthesis of ibandronate
WO2007083243A3 (en) An improved process for the preparation of risedronate sodium hemi-pentahydrate
WO2008152518A3 (en) Process for the preparation of risedronic acid or risedronate sodium
WO2011016738A8 (en) A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate
EP2009016A3 (en) Process for preparing crystalline form of ibandronate sodium
MX2011010934A (en) Process for the preparation of a biphenyl-2-ylcarbamic acid ester.
WO2010090491A2 (en) Novel salts of adefovir dipivoxil and preparation method thereof
EP2051959A4 (en) A novel process for preparing 3-amino-5-fluoro-4-dialkoxypentanoic acid ester

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08808143

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08808143

Country of ref document: EP

Kind code of ref document: A2